Versant Ventures

News, insights, analysis and data

← Back to Versant Ventures profile

Versant Ventures related stories

All articles and analysis

  • VC-Backed IPO Pipeline Keeps Growing
    Dan Primack- 12 April 2010

    Tengion priced its IPO last Friday, becoming the 11th VC-backed company to go public on a U.S. exchange in 2010. It also was the sixth to do so since we last looked /66353/vc-backed-ipo-pipeline-remains-full/ at the VC-backed IPO pipeline (the other newbies were Calix, China Lodging, MaxLinear, Meru Networks and SS&C Technologies). There also have been eight new additions to the pipeline in the past month. That works out to a total of 42 VC-backed companies currently in registration to go public on U.S. exchanges, representing more than $4.6 billion in targeted raise (a net increase of just over $100m). The full pipeline is after the jump...

  • Week in deals, April 12, 2010
    Brad Meikle- 12 April 2010

    Summary of tech companies and other startups in North America that raised venture financing in the past week

  • peHUB Wire: Wednesday, April 7, 2010
    Brad Meikle- 12 April 2010

    Random Ramblings

  • peHUB Wire: Wednesday, April 7, 2010
    Brad Meikle- 12 April 2010

    Random Ramblings

  • Achaogen Raises $65 Million
    VCJ Staff- 7 April 2010

    Achaogen, a San Francisco-based developer of antibiotics to treat life-threatening, multi-drug resistant bacterial infections, has raised $65 million in Series C funding. Frazier Healthcare Ventures led the round, and was joined by Alta Partners and return backers 5AM Ventures, ARCH Venture Partners, Domain Associates, Venrock Associates, Versant Ventures and the Wellcome Trust. The company previously raised around $42 million.

  • Taking Aim at Diabetes
    Tom Stein- 1 April 2010

    Venture-backed startups are coming up with increasingly innovative ways to inject themselves into the $174 billion market

  • VCs Stuff More Companies Into IPO Pipeline
    Dan Primack- 16 March 2010

    Financial Engines priced its IPO above range last night, and just closed its first day of trading up nearly 44 percent. It was the fifth VC-backed IPO to price in 2010, and the third to do so since we last looked at the VC-backed IPO pipeline /63772/vc-backed-ipo-pipeline-fills-up/ (the others were pharma companies AVEO and Anthera). There also have been four new additions to the pipeline in the past month, including the recent filing from Broadsoft. That works out to a net total of 38 VC-backed companies in registration to go public on U.S. exchanges, representing more than $4.5 billion in targeted raise. View the entire pipeline after the jump...

  • Trius Therapeutics Sets IPO Terms
    VCJ Staff- 25 February 2010
  • peHUB Wire: Thursday, February 25, 2010
    Brad Meikle- 25 February 2010

    Random Ramblings

  • peHUB Wire: Thursday, February 25, 2010
    Brad Meikle- 25 February 2010

    Random Ramblings